Current Treatment of Alopecia Areata.
Study Design
- Тип исследования
- Other
- Популяция
- None
- Вмешательство
- Current Treatment of Alopecia Areata. None
- Препарат сравнения
- None
- Первичный исход
- None
- Направление эффекта
- Mixed
- Риск систематической ошибки
- Unclear
Abstract
The number of alopecia areata (AA) clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases, including Jak1, Jak2, Jak3, and tyrosine-protein kinase has increased significantly since the last Research Summit. This fact means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies as well as evolving therapies as with Jak inhibitors.
Кратко
The number of alopecia areata clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases has increased significantly since the last Research Summit, which means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies.
Used In Evidence Reviews
Similar Papers
Annual review of nutrition · 2004
Secular trends in dietary intake in the United States.
Journal of the American Academy of Dermatology · 2002
A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Journal of the American Academy of Dermatology · 2017
The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
Current problems in dermatology · 2015
Alopecia areata.
Drug design, development and therapy · 2019
Minoxidil and its use in hair disorders: a review.
Journal of cosmetic dermatology · 2021